Time for a shift in molecular down staging in luminal breast cancer

Cristofanilli Massimo

首页> 外文期刊>The lancet oncology >Time for a shift in molecular down staging in luminal breast cancer

【24h】

Time for a shift in molecular down staging in luminal breast cancer

机译：在腔乳腺癌中分子下降分期的时间

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2020年第1期|共2页
作者
Cristofanilli Massimo;
展开▼
作者单位

Northwestern Univ Feinberg Sch Med Div Hematol &

Oncol Robert H Lurie Comprehens Canc Ctr Dept;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 诊断分期和分子分型对乳腺癌患者生存的影响:一项基于医院的多中心研究 [J] . Tingting Zuo, Ning Wang, Lixue Xuan, 癌症（英文版） . 2018,第003期
2. Time for a shift in molecular down staging in luminal breast cancer [J] . Cristofanilli Massimo The lancet oncology . 2020,第1期

机译：在腔乳腺癌中分子下降分期的时间
3. Early re-staging and molecular subtype shift surveillance of locally recurrent or metastatic breast cancer: A new PET/CT integrated precise algorithm [J] . Guo Wei, Hao Bing, Luo Nana, Cancer letters . 2018,第期

机译：早期重新分期和分子亚型移位对局部复发或转移性乳腺癌的影响：一种新的PET / CT综合精确算法
4. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype (vol 45, pg 969, 2019) [J] . Di Micco Rosa, Zuber Veronica, Fiacco Enrico, European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2019,第9期

机译：Sentinel节点活组织检查初级全身疗法在节点阳性乳腺癌患者：时间趋势，成像分期功率和节点根据分子亚型（Vol 45，PG 969,2019）
5. Robustness of radiomic breast features of benign lesions and luminal A cancers across MR magnet strengths [C] . Heather M. Whitney, Karen Drukker, Alexandra Edwards, SPIE Medical Imaging Conference . 2018

机译：MR强度对良性病变和管腔A癌的放射乳腺特征的鲁棒性
6. Nuclear Receptor Regulation of a Luminal Breast Cancer Stem Cell Population [D] . Fettig, Lynsey Mae. 2019

机译：腔受体调节腔乳腺癌干细胞群
7. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer [O] . Ling Xu, Jiang-Hong Li, Jing-Ming Ye, 2017

机译：基于美国癌症联合委员会第8版Luminal B人表皮生长因子受体2阴性乳腺癌的癌症分期手册对解剖和预后阶段组进行回顾性生存分析。
8. Corrigendum to “Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype” Eur. J. Surg. Oncol. 45, (6) (2019) 969–975 [O] . Rosa Di Micco, Veronica Zuber, Enrico Fiacco, 2019

机译：勘察到节点阳性乳腺癌患者初级全身治疗后的Sentinel节点活组织检查：时间趋势，根据分子亚型的成像分期力和节点下降“EUR。 J. Surg。 oncol。 45，（6）（2019）969-975
9. Advancing Our Understanding of the Etiologies and Mutational Landscapes of Basal-Like, Luminal A, and Luminal B Breast Cancers. [R] . Li, C., Chinnaiyan, A., Porter, P. 2017

机译：推进我们对基底样，Luminal a和Luminal B乳腺癌的病因和突变景观的理解。

Time for a shift in molecular down staging in luminal breast cancer

著录项

相似文献

相关主题

期刊订阅